Impax Laboratories Inc (NASDAQ:IPXL)

47.77
Delayed Data
As of Jul 06
 +1.46 / +3.15%
Today’s Change
22.12
Today|||52-Week Range
52.10
+50.79%
Year-to-Date

Today’s Trading

Previous close46.31
Today’s open45.74
Day’s range45.43 - 47.85
Volume798,265
Average volume (3 months)787,803
Market cap$3.3B
Dividend yield--
Data as of 07/06/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+6.92%
Earnings growth (next 5 years)+23.50%
Revenue growth (last year)+16.53%
P/E ratio75.3
Price/Sales3.75
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
ANACAnacor Pharmaceutica...+1.17+1.49%
PBYIPuma Biotechnology I...+1.32+1.18%
WXWuXi PharmaTech (Cay...-3.32-7.94%
CBPOChina Biologic Produ...-2.98-2.58%
Data as of 07/06/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.38
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers